Trial NCT04324073
Publication CORIMUNO-SARI-1 - Mariette X, Lancet Rheumatol (2021) (published paper)
Primary outcome on the report: The proportion of patients dead or needing non-invasive ventilation or mechanical ventilation on day 4 (patients with a WHO-CPS score of >5) to be analysed as a binary outcome and survival with no need for non-invasive ventilation (including high-flow oxygen) or mechanical ventilation at day 14, to be analysed as a time-to-event outcome.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.